Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation
British Journal of Radiology · 2024
DOI: 10.1093/bjr/tqae171 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Franco Orsi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Istituto Europeo di Oncologia (IRCCS), Milan, Via Giuseppe Ripamonti 435, Milan-20141, Italy. Hauptthemen laut MEDLINE: Cryosurgery, Bone Neoplasms, Nitrogen, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to assess the complication rate during and 24 hours after cryoablation in lung, bone, and soft tissue tumors.
Methods
We reviewed complications in a total of 85 consecutive patients who underwent cryoablation using a liquid nitrogen-based system in various lesions between April 2017 and October 2022. There were no liver and renal lesions. Complications were categorized using the Society of Interventional Radiology classification.
Results
Eighty-five patients were treated for 96 lesions in the bone (36.4%; 35 of 96), lung (18.8%; 18 of 96), and soft tissue (44.8%; 43 of 96). The primary technical success rate was 97.7% (83 of 85). The total grade 2 and 1 complication rates were 5.2% (5/96) and 20.8% (20/96), respectively. Two patients had asymptomatic pulmonary embolisms incidentally noted at the 24-hour follow-up computed tomography (grade 2). The most frequent complications were simple and hemorrhagic pleural effusions (18.7%; 18 of 96). Lung procedures had the highest complication rate, where 13 patients (72.2%; 13 of 18) reported complications, including 2 cases of symptomatic hydropneumothorax requiring drainage (grade 2) and an additional 2 days of hospital stay. Eight patients (24.2%; 8 of 33) with bone lesions and 4 (9.3%; 4 of 43) with soft tissue lesions experienced complications.
Conclusion
Cryoablation using a liquid nitrogen-based system is safe, with only minor complications observed. Advances in knowledge This study provides data on the safety of liquid nitrogen-based percutaneous cryoablation in tumors located in lung, in bones and in soft tissues. Despite using larger diameter cryoprobes than those typically reported with argon-based system, our experience shows that complications are mostly low and comparable in frequency and severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Radiology, Istituto Europeo di Oncologia (IRCCS), Milan, Via Giuseppe Ripamonti 435, Milan-20141, Italy.
- Selayang Hospital, Selangor, Malaysia.
- Università degli studi di Milano, Milan, 20122, Italy.
ORCID-Profile: Franco Orsi, Caterina Sattin
Zitieren
APA
Orsi, F., Hamiddin, A. S., Sattin, C., Pizzi, C., Varano, G. M., Della Vigna, P., Mauri, G., Maiettini, D., & Bonomo, G. (2024). Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae171
Vancouver
Orsi F, Hamiddin AS, Sattin C, Pizzi C, Varano GM, Della Vigna P, et al. Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae171
BibTeX
@article{Orsi2024,
author = {Orsi, Franco and Hamiddin, Aida Shazlin and Sattin, Caterina and Pizzi, Caterina and Varano, Gianluca Maria and Della Vigna, Paolo and Mauri, Giovanni and Maiettini, Daniele and Bonomo, Guido},
title = {Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation},
journal = {British Journal of Radiology},
year = {2024},
doi = {10.1093/bjr/tqae171}
}
EUVIMED